No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4355122 |
chr2:125346337-125346338 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs537060724 |
chr2:125346347-125346348 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs201616192 |
chr2:125346372-125346373 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs148538797 |
chr2:125346387-125346388 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs562767914 |
chr2:125346590-125346591 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs567725689 |
chr2:125346599-125346600 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs536391561 |
chr2:125346622-125346623 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs192977192 |
chr2:125346630-125346631 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs34892351 |
chr2:125346732-125346733 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs531771955 |
chr2:125346741-125346742 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs1504018 |
chr2:125346766-125346767 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs534887870 |
chr2:125346771-125346772 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs536512311 |
chr2:125346781-125346782 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs145196141 |
chr2:125346796-125346797 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs558100698 |
chr2:125346829-125346830 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs112547812 |
chr2:125346841-125346842 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs543422620 |
chr2:125346847-125346848 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs563321402 |
chr2:125346873-125346874 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs573672256 |
chr2:125346884-125346885 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs542366045 |
chr2:125346911-125346912 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs559849091 |
chr2:125346931-125346932 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs1504017 |
chr2:125346934-125346935 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs547090194 |
chr2:125346951-125346952 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs4848943 |
chr2:125346960-125346961 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs374508640 |
chr2:125346976-125346977 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs531136073 |
chr2:125346983-125346984 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs182903878 |
chr2:125347028-125347029 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs140552354 |
chr2:125347038-125347039 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs6741294 |
chr2:125347053-125347054 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs530162960 |
chr2:125347064-125347065 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546802030 |
chr2:125347108-125347109 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs565833492 |
chr2:125347136-125347137 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs534795105 |
chr2:125347168-125347169 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs558015015 |
chr2:125347204-125347205 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs571565271 |
chr2:125347249-125347250 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs537385586 |
chr2:125347262-125347263 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs549578044 |
chr2:125347286-125347287 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs556877111 |
chr2:125347297-125347298 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs188852118 |
chr2:125347326-125347327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs4848944 |
chr2:125347357-125347358 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs535040330 |
chr2:125347373-125347374 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs552806727 |
chr2:125347424-125347425 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs572925027 |
chr2:125347432-125347433 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs73952838 |
chr2:125347448-125347449 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs576338708 |
chr2:125347498-125347499 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs6715888 |
chr2:125347505-125347506 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs6759754 |
chr2:125347529-125347530 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs555511554 |
chr2:125347553-125347554 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs534208532 |
chr2:125347569-125347570 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs192889723 |
chr2:125347595-125347596 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|